A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011
A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation Source: ERJ Open Res, 5 (4) 00167-2019; 10.1183/23120541.00167-2019 Year: 2019
A retrospective analysis of our lung transplant cohort for the dichotomy within bronchiolitis obliterans syndrome and azithromycin therapy Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008
Post hoc analysis of a randomized trial of azithromycin in bronchiolitis obliterans syndrome after Lung transplantation (BOS); Lung function and survival Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017
Clinical and biological effects of chronic low dose azythromycin treatment in patients with bronchiolitis obliterans Source: Eur Respir J 2007; 30: Suppl. 51, 517s Year: 2007
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011
Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure? Source: Eur Respir J 2011; 37: 10-12 Year: 2011
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004
Multiple breath washout in bronchiolitis obliterans syndrome following paediatric lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012
Azithromycin treatment in patients with BOS after lung transplantation Source: ISSN=ISSN 1810-6838, ISBN=, page=178 Year: 2005
A prospective, open-label pilot-study of azithromycin for lung allograft lymphocytic bronchiolitis: Preliminary results Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights Year: 2010
Ten–years longitudinal study of lung function parameters and elastase activity in lavage fluid in young patients with chronic bronchiolitis obliterans (CBO) Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009
IL8 and IL17 are upregulated in BAL fluid of lung transplant patients with bronchiolitis obliterans syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 465s Year: 2004
A randomized trial of the effectiveness of nebulized therapy with epinephrine compared with salbutamol in the treatment of acute viral bronchiolitis Source: Eur Respir J 2005; 26: Suppl. 49, 127s Year: 2005
The effect of azithromycin on sputum inflammatory markers in bronchiectasis – analysis of a randomized controlled trial Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019
Salutary effect of fructose-1,6-diphosphate in lung injury: a randomized double-blinded placebo clinical trial Source: Annual Congress 2007 - Lung recruitment Year: 2007
The effect of treatment with pirfenidone on death or lung transplantation in patients with idiopathic pulmonary fibrosis (IPF): Analysis of outcomes in the CAPACITY (CAP) trials Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2010
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis Source: Eur Respir J , 49 (3) 1602486; DOI: 10.1183/13993003.02486-2016 Year: 2017
Treatment options in patients with bronchiolitis obliterans syndrome Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005